Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis
- PMID: 31329211
- PMCID: PMC6646974
- DOI: 10.1001/jamaneurol.2019.2044
Lifetime Risk and Heritability of Amyotrophic Lateral Sclerosis
Abstract
Importance: Heritability describes the proportion of variance in the risk of developing a condition that is explained by genetic factors. Although amyotrophic lateral sclerosis (ALS) is known to have a complex genetic origin, disease heritability remains unclear.
Objectives: To determine the extent of ALS heritability and assess the association of sex with disease transmission.
Design, setting, and participants: A prospective population-based parent-offspring heritability study was conducted from January 1, 2008, to December 31, 2017 to assess ALS heritability, and was the first study to assess heritability in the context of known gene mutations of large effect. A total of 1123 incident cases of ALS, diagnosed according to the El Escorial criteria and recorded on the Irish ALS register, were identified. Ninety-two individuals were excluded (non-Irish parental origin [n = 86] and familial ALS [n = 6]), and 1117 patients were included in the final analysis.
Main outcomes and measures: Annual age-specific and sex-specific standardized ALS incidence and mortality-adjusted lifetime risk were determined. Sex-specific heritability estimates were calculated for the overall study cohort, for those known to carry the C9orf72 (OMIM 614260) variant, and for those with no known genetic risk.
Results: A total of 32 parent-child ALS dyads were identified during the study period. Affected offspring were younger at the onset of disease (mean age, 52.0 years; 95% CI, 48.8-55.3 years) compared with their parents (mean age, 69.6 years; 95% CI, 62.4-76.9 years; P = .008). Lifetime risk of developing ALS in first-degree relatives of individuals with ALS was increased compared with the general population (1.4% [32 of 2234] vs 0.3% [2.6 of 1000]; P < .001). Mean lifetime heritability of ALS for the overall study cohort was 52.3% (95% CI, 42.9%-61.7%) and 36.9% (95% CI, 19.8%-53.9%) for those with no known genetic risk. Heritability estimates were highest in mother-daughter pairings (66.2%; 95% CI, 58.5%-73.9%).
Conclusions and relevance: This population-based study confirms that up to 50% of variance in ALS has a genetic basis, and that the presence of the C9orf72 variant is an important determinant of heritability. First-degree relatives of individuals with ALS without a known genetic basis remain at increased risk of developing ALS compared with the general population. A higher heritability estimate in mother-daughter pairings points to a sex-mediated effect that has been previously unrecognized.
Conflict of interest statement
Figures

Similar articles
-
Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.JAMA Neurol. 2017 Dec 1;74(12):1425-1430. doi: 10.1001/jamaneurol.2017.2699. JAMA Neurol. 2017. PMID: 29049464 Free PMC article.
-
Genome-wide analysis of the heritability of amyotrophic lateral sclerosis.JAMA Neurol. 2014 Sep;71(9):1123-34. doi: 10.1001/jamaneurol.2014.1184. JAMA Neurol. 2014. PMID: 25023141 Free PMC article.
-
Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study.Lancet Neurol. 2021 May;20(5):373-384. doi: 10.1016/S1474-4422(21)00042-9. Lancet Neurol. 2021. PMID: 33894192
-
Estimated Prevalence and Incidence of Amyotrophic Lateral Sclerosis and SOD1 and C9orf72 Genetic Variants.Neuroepidemiology. 2021;55(5):342-353. doi: 10.1159/000516752. Epub 2021 Jul 9. Neuroepidemiology. 2021. PMID: 34247168 Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Role of oxidative stress in neurodegenerative disorders: a review of reactive oxygen species and prevention by antioxidants.Brain Commun. 2024 Jan 2;6(1):fcad356. doi: 10.1093/braincomms/fcad356. eCollection 2024. Brain Commun. 2024. PMID: 38214013 Free PMC article. Review.
-
Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types.Adv Neurobiol. 2024;37:531-544. doi: 10.1007/978-3-031-55529-9_29. Adv Neurobiol. 2024. PMID: 39207711 Review.
-
The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy.Mol Neurobiol. 2023 Nov;60(11):6330-6345. doi: 10.1007/s12035-023-03472-y. Epub 2023 Jul 14. Mol Neurobiol. 2023. PMID: 37450244 Free PMC article. Review.
-
Characterising the Genetic Landscape of Amyotrophic Lateral Sclerosis: A Catalogue and Assessment of Over 1,000 Published Genetic Variants.J Neuromuscul Dis. 2023;10(6):1127-1141. doi: 10.3233/JND-230148. J Neuromuscul Dis. 2023. PMID: 37638449 Free PMC article.
-
ALS in Danish Registries: Heritability and links to psychiatric and cardiovascular disorders.Neurol Genet. 2020 Feb 20;6(2):e398. doi: 10.1212/NXG.0000000000000398. eCollection 2020 Apr. Neurol Genet. 2020. PMID: 32211514 Free PMC article.
References
-
- Falconer DS. The inheritance of liability to certain diseases, estimated from the incidence among relatives. Ann Hum Genet. 1965;29(1):51-76. doi:10.1111/j.1469-1809.1965.tb00500.x - DOI
-
- Estève J, Benhamou E, Raymond L. Statistical methods in cancer research, volume IV: descriptive epidemiology. IARC Sci Publ. 1994;(128):1-302. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous